ORIGINAL RESEARCH
Published on 19 Feb 2025
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction
doi 10.3389/fphar.2025.1540477
- 120 views